Restricting calorie intake in species such as mice, rhesus monkeys, and fruit flies has been shown to extend their lifespans.
Ultomiris demonstrated statistically significant and clinically meaningful reduction of proteinuria in adults with IgAN in I CAN phase III trial: Cambridge, UK Wednesday, April 22 ...
Yale researchers have previously shown that people who undergo moderate calorie restriction—a 14% reduction in calorie intake ...
Carbon Core EMS ab stimulator 2026 availability: multi-zone belt, arm, and leg strap training system now offered ...
Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...
Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the contribution of the lectin pathway remains unclear. Lectin pathway-dependent ...
Promising Late-Stage Drugs Signal A New Treatment Era Delveinsight. The generalized myasthenia gravis treatment pipeline ...
US FDA clears Corify Care’s ACORYS system, a 4-D electroanatomical cardiac mapping in real-time: Madrid, Spain Monday, April 20, 2026, 14:00 Hrs [IST] Corify Care, a MedTech com ...
As published in The Lancet and presented at AAN, NIMBLE trial met its primary and key secondary endpoints at week 24, demonstrating potential ...
EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in CanadaApproval supported ...
Therapeutic fasting offers a metabolic approach to chronic pain by shifting to fat metabolism, reducing systemic inflammation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results